Hayward NK - Search Results

1

Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas.

Vidal MJ, Loganzo F Jr, de Oliveira AR, Hayward NK, Albino AP. Vidal MJ, et al. Among authors: hayward nk. Melanoma Res. 1995 Aug;5(4):243-50. doi: 10.1097/00008390-199508000-00006. Melanoma Res. 1995. PMID: 7496159

2

Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1.

Grimmond S, Weber G, Larsson C, Walters M, Teh B, Shepherd J, Nordenskjold M, Hayward N. Grimmond S, et al. Hum Genet. 1995 Apr;95(4):455-8. doi: 10.1007/BF00208976. Hum Genet. 1995. PMID: 7535744

3

Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines.

Pollock PM, Yu F, Qiu L, Parsons PG, Hayward NK. Pollock PM, et al. Among authors: hayward nk. Oncogene. 1995 Aug 17;11(4):663-8. Oncogene. 1995. PMID: 7651729

4

Microsatellite instability in melanoma.

Walker GJ, Palmer JM, Walters MK, Nancarrow DJ, Hayward NK. Walker GJ, et al. Among authors: hayward nk. Melanoma Res. 1994 Aug;4(4):267-8. doi: 10.1097/00008390-199408000-00009. Melanoma Res. 1994. PMID: 7950362 No abstract available.

5

Haplotype analysis limits the position of the familial melanoma locus on 9p to the D9S169-D9S156 interval.

Walker GJ, Nancarrow DJ, Palmer JM, Walters MK, Hayward NK. Walker GJ, et al. Among authors: hayward nk. Melanoma Res. 1994 Feb;4(1):29-34. doi: 10.1097/00008390-199402000-00005. Melanoma Res. 1994. PMID: 8032215

6

Mutation and expression of the p53 gene in human malignant melanoma.

Albino AP, Vidal MJ, McNutt NS, Shea CR, Prieto VG, Nanus DM, Palmer JM, Hayward NK. Albino AP, et al. Among authors: hayward nk. Melanoma Res. 1994 Feb;4(1):35-45. doi: 10.1097/00008390-199402000-00006. Melanoma Res. 1994. PMID: 8032216

7

Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds.

Walker GJ, Hussussian CJ, Flores JF, Glendening JM, Haluska FG, Dracopoli NC, Hayward NK, Fountain JW. Walker GJ, et al. Among authors: hayward nk. Hum Mol Genet. 1995 Oct;4(10):1845-52. doi: 10.1093/hmg/4.10.1845. Hum Mol Genet. 1995. PMID: 8595405

8

Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.

Pollock PM, Pearson JV, Hayward NK. Pollock PM, et al. Among authors: hayward nk. Genes Chromosomes Cancer. 1996 Feb;15(2):77-88. doi: 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0. Genes Chromosomes Cancer. 1996. PMID: 8834170 Review.

9

Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.

Flores JF, Walker GJ, Glendening JM, Haluska FG, Castresana JS, Rubio MP, Pastorfide GC, Boyer LA, Kao WH, Bulyk ML, Barnhill RL, Hayward NK, Housman DE, Fountain JW. Flores JF, et al. Among authors: hayward nk. Cancer Res. 1996 Nov 1;56(21):5023-32. Cancer Res. 1996. PMID: 8895759

10

CDKN2A/p16 is inactivated in most melanoma cell lines.

Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG, Hayward NK. Castellano M, et al. Among authors: hayward nk. Cancer Res. 1997 Nov 1;57(21):4868-75. Cancer Res. 1997. PMID: 9354451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results